Who invested in Syapse?
Syapse's investors include Social Capital, The Social+Capital Partnership, Safeguard Scientifics, Ascension and Merck Global Health Innovation Fund, and 5 more on record.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$45Mraised across 4 rounds since 2011, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEs
From a historical funding recordSEC filing: $10.0M sold, first sale Jun 2014
From the SEC filings it signed: 4 on the team.
On the board, as filediAlexander HardyFrank WilliamsGary KurtzmanJay ZaveriJohn Kuelper
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Syapse's investors include Social Capital, The Social+Capital Partnership, Safeguard Scientifics, Ascension and Merck Global Health Innovation Fund, and 5 more on record.
Syapse has raised $45M across 4 rounds since 2011.
Syapse's most recent round was a Series D of $30M in Nov 2017.
Its most recent round, $30M in Nov 2017, is also its largest on record.
Syapse's first round on record, in Jan 2013, was backed by Social Capital and The Social+Capital Partnership.
Syapse's latest named round is a Series D, in Nov 2017.
Syapse is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.